Blockchain Registration Transaction Record

VolitionRx Achieves Milestone with Finger-Prick Sepsis Detection Prototype

VolitionRx announces successful detection of nucleosomes in capillary blood from sepsis patients using a finger-prick prototype, expanding point-of-care testing and addressing global sepsis mortality.

This news matters because sepsis is a life-threatening condition that requires rapid detection and treatment. VolitionRx's finger-prick prototype could enable early diagnosis in remote or resource-limited settings, potentially saving countless lives by catching sepsis before it becomes critical. The ability to test at point-of-care without lab infrastructure democratizes access to advanced diagnostics, which is crucial for improving global health outcomes.